Cargando…
Clusterin confers gmcitabine resistance in pancreatic cancer
OBJECTIVE: To measure clusterin expression in pancreatic cancer tissues and cell lines and to evaluate whether clusterin confers resistance to gmcitabine in pancreatic cancer cells. METHODS: Immunohistochemistry for clusterin was performed on 50 primary pancreatic cancer tissues and 25 matched backg...
Autores principales: | Chen, Qingfeng, Wang, Zhengkun, Zhang, Kejun, Liu, Xiaoyi, Cao, Weihong, Zhang, Lei, Zhang, Shuhua, Yan, Bomin, Wang, Yaoguang, Xia, Chunping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120680/ https://www.ncbi.nlm.nih.gov/pubmed/21609464 http://dx.doi.org/10.1186/1477-7819-9-59 |
Ejemplares similares
-
Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2013) -
Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin
por: Chen, Dong, et al.
Publicado: (2012) -
Correction: Liang, J., et al. Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin. Int. J. Mol. Sci. 2012, 13, 10594–10607
por: Chen, Dong, et al.
Publicado: (2013) -
Clusterin transduces Alzheimer-risk signals to amyloidogenesis
por: Liu, Xi, et al.
Publicado: (2022) -
Clinical significance of clusterin expression in pancreatic adenocarcinoma
por: Jin, Junshuo, et al.
Publicado: (2012)